Logo image of MNTS

MOMENTUS INC (MNTS) Stock Fundamental Analysis

NASDAQ:MNTS - Nasdaq - US60879E3099 - Common Stock - Currency: USD

1.89  -0.01 (-0.53%)

After market: 1.89 0 (0%)

Fundamental Rating

1

Overall MNTS gets a fundamental rating of 1 out of 10. We evaluated MNTS against 65 industry peers in the Aerospace & Defense industry. MNTS may be in some trouble as it scores bad on both profitability and health. MNTS is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year MNTS has reported negative net income.
MNTS had a negative operating cash flow in the past year.
In the past 5 years MNTS reported 4 times negative net income.
MNTS had a negative operating cash flow in each of the past 5 years.
MNTS Yearly Net Income VS EBIT VS OCF VS FCFMNTS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 50M -50M 100M

1.2 Ratios

With a Return On Assets value of -351.15%, MNTS is not doing good in the industry: 98.46% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -351.15%
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
MNTS Yearly ROA, ROE, ROICMNTS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 -100 -200

1.3 Margins

With an excellent Gross Margin value of 96.88%, MNTS belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
MNTS's Gross Margin has declined in the last couple of years.
MNTS does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 96.88%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-12.05%
GM growth 5YN/A
MNTS Yearly Profit, Operating, Gross MarginsMNTS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 20K -20K

More info and screens

0

2. Health

2.1 Basic Checks

MNTS does not have a ROIC to compare to the WACC, probably because it is not profitable.
There is no outstanding debt for MNTS. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
MNTS Yearly Shares OutstandingMNTS Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 1M 2M 3M 4M
MNTS Yearly Total Debt VS Total AssetsMNTS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 50M 100M 150M

2.2 Solvency

MNTS has an Altman-Z score of -67.95. This is a bad value and indicates that MNTS is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of -67.95, MNTS is not doing good in the industry: 96.92% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -67.95
ROIC/WACCN/A
WACC9.76%
MNTS Yearly LT Debt VS Equity VS FCFMNTS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 50M -50M 100M 150M

2.3 Liquidity

A Current Ratio of 0.30 indicates that MNTS may have some problems paying its short term obligations.
The Current ratio of MNTS (0.30) is worse than 95.38% of its industry peers.
MNTS has a Quick Ratio of 0.30. This is a bad value and indicates that MNTS is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.30, MNTS is not doing good in the industry: 95.38% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.3
Quick Ratio 0.3
MNTS Yearly Current Assets VS Current LiabilitesMNTS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 50M 100M 150M

More info and screens

3

3. Growth

3.1 Past

MNTS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 17.27%, which is quite good.
Looking at the last year, MNTS shows a very negative growth in Revenue. The Revenue has decreased by -31.63% in the last year.
MNTS shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 85.72% yearly.
EPS 1Y (TTM)17.27%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-90.89%
Revenue 1Y (TTM)-31.63%
Revenue growth 3Y85.72%
Revenue growth 5YN/A
Sales Q2Q%-72.14%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-270.86%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year60%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
MNTS Yearly Revenue VS EstimatesMNTS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 2M 4M 6M 8M
MNTS Yearly EPS VS EstimatesMNTS Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 -200 -400 -600 -800

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for MNTS. In the last year negative earnings were reported.
Also next year MNTS is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
MNTS Price Earnings VS Forward Price EarningsMNTS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
MNTS Per share dataMNTS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -10 -20 -30

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for MNTS!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

MOMENTUS INC

NASDAQ:MNTS (4/25/2025, 8:24:23 PM)

After market: 1.89 0 (0%)

1.89

-0.01 (-0.53%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryAerospace & Defense
Earnings (Last)04-01 2025-04-01/amc
Earnings (Next)10-13 2025-10-13
Inst Owners8.3%
Inst Owner Change0%
Ins Owners0.31%
Ins Owner Change4.71%
Market Cap9.94M
Analysts82.86
Price TargetN/A
Short Float %5.47%
Short Ratio0.9
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-85.17%
Min Revenue beat(2)-88.96%
Max Revenue beat(2)-81.37%
Revenue beat(4)0
Avg Revenue beat(4)-59.59%
Min Revenue beat(4)-88.96%
Max Revenue beat(4)-20.98%
Revenue beat(8)2
Avg Revenue beat(8)31.15%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 4.7
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-25.81
EYN/A
EPS(NY)-34.27
Fwd EYN/A
FCF(TTM)-3.17
FCFYN/A
OCF(TTM)-3.16
OCFYN/A
SpS0.4
BVpS-1.48
TBVpS-1.53
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -351.15%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 96.88%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-12.05%
GM growth 5YN/A
F-Score4
Asset Turnover0.21
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 4.78%
Cap/Sales 1.94%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.3
Quick Ratio 0.3
Altman-Z -67.95
F-Score4
WACC9.76%
ROIC/WACCN/A
Cap/Depr(3y)30.06%
Cap/Depr(5y)N/A
Cap/Sales(3y)87.63%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)17.27%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-90.89%
EPS Next Y-270.86%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-31.63%
Revenue growth 3Y85.72%
Revenue growth 5YN/A
Sales Q2Q%-72.14%
Revenue Next Year60%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y56.46%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year33.24%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y73.12%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y73.13%
OCF growth 3YN/A
OCF growth 5YN/A